| Dr David Bryan Schwimmer, MD | |
|
3325 S Tamiami Trl Ste 200, Sarasota, FL 34239-5142 | |
| (941) 952-9223 | |
| (941) 955-0642 |
| Full Name | Dr David Bryan Schwimmer |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 10 Years |
| Location | 3325 S Tamiami Trl Ste 200, Sarasota, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245641380 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | ME132855 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sarasota Memorial Hospital | Sarasota, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Digestive Health Specialists, Llp | 6507054582 | 78 |
News Archive
Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.
Understanding how nitrite can improve conditions such as hypertension, heart attack and stroke has been the object of worldwide research studies. New research from Wake Forest University has potentially moved the science one step closer to this goal.
Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.
Disclosure of HIV positive serostatus to sexual partners is considered an important public health goal to prevent new infections. Disclosure can motivate sex partners to make informed choices and change behavior through negotiation of safer sex practices. It might also prompt partner testing and counseling.
The President will sign an executive order Wednesday at 2:30 p.m. in a much smaller ceremony than the one for the health care reform bill Tuesday.
› Verified 6 days ago
| Entity Name | Florida Digestive Health Specialists, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518267327 PECOS PAC ID: 6507054582 Enrollment ID: O20101216000875 |
News Archive
Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.
Understanding how nitrite can improve conditions such as hypertension, heart attack and stroke has been the object of worldwide research studies. New research from Wake Forest University has potentially moved the science one step closer to this goal.
Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.
Disclosure of HIV positive serostatus to sexual partners is considered an important public health goal to prevent new infections. Disclosure can motivate sex partners to make informed choices and change behavior through negotiation of safer sex practices. It might also prompt partner testing and counseling.
The President will sign an executive order Wednesday at 2:30 p.m. in a much smaller ceremony than the one for the health care reform bill Tuesday.
› Verified 6 days ago
| Entity Name | Tampa General Provider Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538742317 PECOS PAC ID: 6002217346 Enrollment ID: O20210624001725 |
News Archive
Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.
Understanding how nitrite can improve conditions such as hypertension, heart attack and stroke has been the object of worldwide research studies. New research from Wake Forest University has potentially moved the science one step closer to this goal.
Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.
Disclosure of HIV positive serostatus to sexual partners is considered an important public health goal to prevent new infections. Disclosure can motivate sex partners to make informed choices and change behavior through negotiation of safer sex practices. It might also prompt partner testing and counseling.
The President will sign an executive order Wednesday at 2:30 p.m. in a much smaller ceremony than the one for the health care reform bill Tuesday.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Bryan Schwimmer, MD 3325 S Tamiami Trl Ste 200, Sarasota, FL 34239-5142 Ph: (941) 952-9223 | Dr David Bryan Schwimmer, MD 3325 S Tamiami Trl Ste 200, Sarasota, FL 34239-5142 Ph: (941) 952-9223 |
News Archive
Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.
Understanding how nitrite can improve conditions such as hypertension, heart attack and stroke has been the object of worldwide research studies. New research from Wake Forest University has potentially moved the science one step closer to this goal.
Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.
Disclosure of HIV positive serostatus to sexual partners is considered an important public health goal to prevent new infections. Disclosure can motivate sex partners to make informed choices and change behavior through negotiation of safer sex practices. It might also prompt partner testing and counseling.
The President will sign an executive order Wednesday at 2:30 p.m. in a much smaller ceremony than the one for the health care reform bill Tuesday.
› Verified 6 days ago
Fadi Kayali, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 600 N Cattlemen Rd, Suite 200, Sarasota, FL 34232 Phone: 941-377-9993 Fax: 941-343-0026 | |
Dr. Eduardo Jose Lazaro, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5731 Bee Ridge Rd, Sarasota, FL 34233 Phone: 727-808-5824 | |
Dr. Scott D. Lunin, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1970 Golf St, Sarasota, FL 34236 Phone: 941-957-1000 Fax: 941-951-2117 | |
Dr. Robert L Oppenheimer, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1921 Waldemere St, Suite 605, Sarasota, FL 34239 Phone: 941-917-8100 Fax: 941-917-6334 | |
Edward Renan Bermudez, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3920 Bee Ridge Rd, Bldg E, Suite F-201, Sarasota, FL 34233 Phone: 941-917-8744 Fax: 941-917-8749 | |
Dr. Stephen C Culp, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3830 Bee Ridge Rd, Suite 201, Sarasota, FL 34233 Phone: 941-929-7272 Fax: 941-929-1044 | |
Dr. Suzanne R Lutton, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5951 Cattleridge Ave Ste 100, Sarasota, FL 34232 Phone: 941-379-1850 Fax: 941-379-1855 |